WHO ICTRP trial
Research on the Mechanism of ARRDC4 Mediating Microvascular Dysfunction in…
ChiCTR2500099121 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500099121 |
|---|---|
| Public title | Research on the Mechanism of ARRDC4 Mediating Microvascular Dysfunction in Diabetic Retinopathy |
| Scientific title | Research on the Mechanism of ARRDC4 Mediating Microvascular Dysfunction in Diabetic Retinopathy |
| Primary sponsor | The First People's Hospital of Yibin |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Countries | China |
| Conditions | Diabetic retinopathy |
| Interventions | Healthy control group,:None;Non-proliferative diabetic retinopathy (NPDR) group :None;Proliferative diabetic retinopathy (PDR) group:None |
| Registration date | Mar 18, 2025 |
| Target size | Healthy control group,:55;Non-proliferative diabetic retinopathy (NPDR) group… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: